Cas:471270-60-7 6-(2-Hydroxybenzylamino)-2-(3-hydroxypropylamino)-9-isopropylpurine manufacturer & supplier

We serve Chemical Name:6-(2-Hydroxybenzylamino)-2-(3-hydroxypropylamino)-9-isopropylpurine CAS:471270-60-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

6-(2-Hydroxybenzylamino)-2-(3-hydroxypropylamino)-9-isopropylpurine

Chemical Name:6-(2-Hydroxybenzylamino)-2-(3-hydroxypropylamino)-9-isopropylpurine
CAS.NO:471270-60-7
Synonyms:2-[[[2-(3-hydroxypropylamino)-9-propan-2-ylpurin-6-yl]amino]methyl]phenol
Molecular Formula:C18H24N6O2
Molecular Weight:356.42200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:108.12000
Exact Mass:356.19600
LogP:2.66520

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-[[[2-(3-hydroxypropylamino)-9-propan-2-ylpurin-6-yl]amino]methyl]phenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-[[[2-(3-hydroxypropylamino)-9-propan-2-ylpurin-6-yl]amino]methyl]phenol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-[[[2-(3-hydroxypropylamino)-9-propan-2-ylpurin-6-yl]amino]methyl]phenol Use and application,2-[[[2-(3-hydroxypropylamino)-9-propan-2-ylpurin-6-yl]amino]methyl]phenol technical grade,usp/ep/jp grade.


Related News: As a global-risk medical practice transforming care of the neediest populations, our centers are located in underserved neighborhoods,” notes Faisel Syed, M.D., ChenMed National Director of Primary Care. vanadium(4+) manufacturers EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions. radon(•1+) suppliers Specifically, the EC has cleared Verquvo (vericiguat) to treat patients who are stabilised after a recent decompensation event requiring intravenous therapy. diphenylmethyl 7β-tert-butoxycarbonylamino-3-(3-pyridyl)methylthiomethyl-3-cephem-4-carboxylate vendor & factory.